Stock GVS GVS S.P.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials GVS S.p.A.

Equities

GVS

IT0005411209

Medical Equipment, Supplies & Distribution

Market Closed - Borsa Italiana
Other stock markets
 11:44:59 2024-06-07 am EDT 		5-day change 1st Jan Change
7 EUR -0.28% Intraday chart for GVS S.p.A. +5.58% +25.56%
Jun. 04 Futures down; focus on ECB cuts AN
Jun. 03 Mib bullish; Telecom Italia takes top spot AN

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,669 1,847 706.9 974.4 1,223 - -
Enterprise Value (EV) 1 2,642 1,943 706.9 1,303 1,516 1,449 1,389
P/E ratio - - 28.9 x 69.7 x 32.3 x 22.1 x 18.7 x
Yield 0.85% - - - - 1.05% 1.79%
Capitalization / Revenue 7.35 x 5.38 x 1.8 x 2.25 x 2.78 x 2.61 x 2.45 x
EV / Revenue 7.27 x 5.66 x 1.8 x 3.01 x 3.45 x 3.09 x 2.79 x
EV / EBITDA 18.3 x 18 x 8.95 x 13.7 x 14.1 x 11.4 x 9.72 x
EV / FCF - - - 17.8 x 35.9 x 22.4 x 19.6 x
FCF Yield - - - 5.63% 2.78% 4.47% 5.1%
Price to Book - - - - 3.33 x 2.83 x 2.55 x
Nbr of stocks (in thousands) 175,000 175,067 174,550 174,773 174,759 - -
Reference price 2 15.25 10.55 4.050 5.575 7.000 7.000 7.000
Announcement Date 3/19/21 3/22/22 3/21/23 3/26/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 363.3 343.1 392 432.4 439.9 468.6 498.5
EBITDA 1 144.1 107.9 79 95.1 107.5 127 143
EBIT 1 128.6 89.3 54.8 67.4 79.25 96.88 113
Operating Margin 35.4% 26.03% 13.98% 15.59% 18.02% 20.68% 22.67%
Earnings before Tax (EBT) 1 - - 34.6 18.3 52 76 89.5
Net income 1 - - 24.1 13.6 38 55.65 65.8
Net margin - - 6.15% 3.15% 8.64% 11.88% 13.2%
EPS 2 - - 0.1400 0.0800 0.2170 0.3170 0.3740
Free Cash Flow 1 - - - 73.39 42.2 64.8 70.85
FCF margin - - - 16.97% 9.59% 13.83% 14.21%
FCF Conversion (EBITDA) - - - 77.17% 39.24% 51.04% 49.55%
FCF Conversion (Net income) - - - 539.65% 111.05% 116.44% 107.67%
Dividend per Share 2 0.1300 - - - - 0.0733 0.1250
Announcement Date 3/19/21 3/22/22 3/21/23 3/26/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2
Net sales 1 81.53 - - 116 104.9 109.4 213.4 99.74 114.6 103.9 113.6
EBITDA - - - - 22.6 - - 21.64 27.84 24.3 -
EBIT - - - - 12.1 - - 15.23 18.4 13.1 -
Operating Margin - - - - 11.53% - - 15.27% 16.06% 12.61% -
Earnings before Tax (EBT) - - - - - - - - - - -
Net income - 32.44 12.64 - 2.5 - - 8.469 -2.2 9.4 -
Net margin - - - - 2.38% - - 8.49% -1.92% 9.05% -
EPS - 0.1900 0.0700 - - - - - - - -
Dividend per Share - - - - - - - - - - -
Announcement Date 3/22/22 7/30/22 11/11/22 3/21/23 5/15/23 9/7/23 9/7/23 11/9/23 3/26/24 5/14/24 -
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - 96.5 - 329 292 225 166
Net Cash position 1 26.7 - - - - - -
Leverage (Debt/EBITDA) - 0.8944 x - 3.456 x 2.718 x 1.775 x 1.161 x
Free Cash Flow 1 - - - 73.4 42.2 64.8 70.9
ROE (net income / shareholders' equity) - - - 4.12% - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share 2 - - - - 2.100 2.480 2.750
Cash Flow per Share 2 - - - 0.6000 -0.0100 0.2600 0.2900
Capex 1 - - - 28.2 36.5 28.4 29.7
Capex / Sales - - - 6.52% 8.3% 6.05% 5.95%
Announcement Date 3/19/21 3/22/22 3/21/23 3/26/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for GVS S.p.A.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
7 EUR
Average target price
6.467 EUR
Spread / Average Target
-7.62%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Supplies

1st Jan change Capi.
GVS S.P.A. Stock GVS S.p.A.
+25.56% 1.32B
COLOPLAST A/S Stock Coloplast A/S
+8.91% 27.39B
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED Stock Shandong Weigao Group Medical Polymer Company Limited
-41.00% 2.63B
HARTALEGA HOLDINGS Stock Hartalega Holdings
+26.30% 2.48B
INTCO MEDICAL TECHNOLOGY CO., LTD. Stock Intco Medical Technology Co., Ltd.
+5.99% 2.21B
TOP GLOVE CORPORATION BHD. Stock Top Glove Corporation Bhd.
+24.44% 1.91B
HARBIN FUERJIA TECHNOLOGY CO., LTD. Stock Harbin Fuerjia Technology Co., Ltd.
-14.16% 1.81B
KOSSAN RUBBER INDUSTRIES Stock Kossan Rubber Industries
+33.51% 1.34B
NAKANISHI INC. Stock Nakanishi Inc.
-2.45% 1.25B
RIVERSTONE HOLDINGS LIMITED Stock Riverstone Holdings Limited
+34.04% 1.04B
Medical Supplies
  1. Stock Market
  2. Equities
  3. GVS Stock
  4. Financials GVS S.p.A.